Back to results
US 2018/0008613 A1Published application
Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment
AssigneeNeurodyn Life Sciences Inc.
InventorAlfred Maelicke
Life of this patent
Estimating the term…
Abstract
A method for the treatment of a neurodegenerative, psychiatric or neurological disease associated with a cholinergic deficit comprising administering GLN-1062 or a pharmaceutically acceptable salt thereof by nasal administration to a patient in need thereof.
Claims8
A method for the treatment of a neurodegenerative, psychiatric or neurological disease associated with a cholinergic deficit comprising administering GLN-1062:
- or a pharmaceutically acceptable salt thereof by nasal administration to a patient in need thereof.
Dependencies are inferred from the claim text.